Calls for drugs produced in the U.S. have led to a cottage industry of contract manufacturers hoping to market themselves as "American made." Now, a new CDMO specializing in sterile injectables is launching in Indiana, and it's got $60 million to get the business off the ground.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,